Journal of Nutrition and Health

  • 제40권3호
  • /
  • Pages.249-258
  • /
  • 2007
  • /
  • 2288-3886(pISSN)
  • /
  • 2288-3959(eISSN)
한국영양학회 (The Korean Nutrition Society)
권호 표지

전립선비대증에 영향을 미치는 식생활 및 생활습관 요인

Diet and Lifestyle Risk Factors of Benign Prostatic Hyperplasia

  • 김은정 (이화여자대학교 생활환경대학 식품영양학과, 의과대학 예방의학교실) ;
  • 박혜숙 (이화여자대학교 생활환경대학 식품영양학과, 의과대학 예방의학교실) ;
  • 김혜숙 (이화여자대학교 생활환경대학 식품영양학과, 의과대학 예방의학교실) ;
  • 장남수 (이화여자대학교 생활환경대학 식품영양학과, 의과대학 예방의학교실)
  • Kim, Eun-Jung (Department of Nutritional Sciences and Preventive Medicine, Ewha Womans University) ;
  • Park, Hye-Sook (Department of Nutritional Sciences and Preventive Medicine, Ewha Womans University) ;
  • Kim, Hye-Sook (Department of Nutritional Sciences and Preventive Medicine, Ewha Womans University) ;
  • Chang, Nam-Soo (Department of Nutritional Sciences and Preventive Medicine, Ewha Womans University)
  • 발행 : 2007.04.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Benign prostatic hyperplasia (BPH) is one the most common prostate diseases in middle aged and elderly men. This study was conducted to investigate diet and lifestyle risk factors for benign prostatic hyperplasia in a community-dwelling free-living population group. The dietary data were collected from the 601 male subjects aged 50-79 years using the 24-hour recall method. The mean age of the BPH group ($63.0{\pm}7.9$ years) was significantly higher than that of the non-BPH ($58.8{\pm}7.4$ years). Among many nutrients, the amount of animal fat intake was increased while that of carbohydrate intake decreased in subjects with BPH compared to those with non-BPH. In BPH subjects, the proportion of energy from fat was also greater than in subjects with non-BPH. The logistic regression analysis on the food consumption data showed that the consumption of total animal food was increased while that of mushrooms was decreased in patients with BPH compared to the subjects with non-BPH. The age-adjusted odds ratios and 95% confidences limits for BPH incidence in subjects whose milk and milk products, beverages and alcoholic liquors intake was greater than the median were 1.796 (1.167-2.782) and 1.738 (1.129-2.676) respectively, compared to those in subjects whose intakes were below the median. These results may be applicable in the development of a nutrition intervention and education program toward a reduction in the risk for benign prostatic hyperplasia.

키워드

참고문헌

  1. Griffiths K, Denis L, Turkes A, Morton MS. Phytoestrogens and diseases of the prostate gland. Baillieres Clin Endocrinol Metab 1998; 12(4): 625-647 https://doi.org/10.1016/S0950-351X(98)80008-6
  2. Ziada A, Rosenblum M, Crawford ED. Benign prostatic hyperplasia: an overview. Urology 1999; 53(sup 3A): 1-6
  3. Ekman P. BPH epidemiology and risk factors. Prostate 1989; 2(sup): 23-31 https://doi.org/10.1002/pros.2990020104
  4. Caine M. The present role of ${\alpha}-adrenergic$ blockers in the treatment of benign prostatic hypertrophy. J Urol 1986; 136: 1-4 https://doi.org/10.1016/S0022-5347(17)44709-4
  5. Willett WC. Nutritional Epidemiology. 2nd ed. P.273-301, Oxford University Press. New York; 1998
  6. Suzuki S, Platz EA, Kawachi I, Willett WC, Giovannucci E. Intakes of energy and macronutrients and the risk of benign prostatic hyperplasia. Am J Clin Nut 2002; 75(4): 689-669 https://doi.org/10.1093/ajcn/75.4.689
  7. Lagiou P, Wuu J, Trichopoulou A, Hsieh CC, Adami HO, Trichopoulos D. Diet and benign prostatic hyperplasia: A study in Greece. Urology 1999; 54: 284-290 https://doi.org/10.1016/S0090-4295(99)00096-5
  8. Araki H, Watanabe H, Mishina T, Nakao Ml. High-risk group for benign prostatic hypertrophy. Prostate 1983; 4: 253-264 https://doi.org/10.1002/pros.2990040305
  9. Chyou PH, Normura AM, Stemmermann GN, Hankin JH. A prospective study of alcohol, diet and other lifestyle factors in relation to obstructive uropathy. Prostate 1993; 22: 253-264 https://doi.org/10.1002/pros.2990220308
  10. Gass R. Benign prostatic hyperplasia: the opposite effects of alcohol and coffee intake. BJU Int 2002; 90(7): 649-654 https://doi.org/10.1046/j.1464-410X.2002.03001.x
  11. Park HS, Chang NS, Kim EJ, Yun HN, Lee HJ, Lee BE, Kim HH, Kwon SW, Jeong YJ. Association between nutrient intakes and benign prostate hyperplasia. Korean J Nutr 2004; 37(9): 801-808
  12. Hyun TS, Han YH. Comparison of folate intake and food sources in college students using the 6th vs 7th nutrient database. Korean J Nutr 2001; 34(7): 797-808
  13. National Rural Living Science Institute. Vitamin B6, Pantothenic acid, Vitamin B12, Folate, Vitamin D, Vitamin E, Vitamin K Content of Food (6th revision); 2002
  14. Dietary Reference Intakes for Koreans, The Korean Nutrition Society, Seoul; 2005
  15. Soygur T, Kupeli B, Aydos K, Kupeli S, Arikan N, Muftuoglu YZ. Effect of obesity on prostatic hyperplasia: its relation to sex steroid levels. Int Urol Nephrol 1996; 28(1): 55-59 https://doi.org/10.1007/BF02550138
  16. Daniell HW. Larger prostatic adenomas in obese men with no associated increase in obstructive uropathy. J Urol 1993; 149: 315-317 https://doi.org/10.1016/S0022-5347(17)36067-6
  17. Schuurman AG, Goldbohm RA, Dorant E, van den Brandt PA. Anthropometry in relation to prostate cancer risk in the Netherlands Cohort Study. Am J Epidemiol 2000; 151: 541-549 https://doi.org/10.1093/oxfordjournals.aje.a010241
  18. Yoon GA, Kim WY, Kim SH. The effect of the dietary carbohydrate on lipid and Ca metabolism, and the immune function in aged rats. Korean J Nutr 1987; 20(2): 135-144
  19. Bray GA, Popkin BM. Dietary fat intake does affect obesity. Am J Cin Nutr 1998; 68: 1157-1173 https://doi.org/10.1093/ajcn/68.6.1157
  20. Wang Y, Corr JG, Thaler HT, Tao Y, Fair WR, Heston WD. Decreased growth of established human prostate LNCaP tumors in mice fed a low-fat diet. J Natl Cancer Inst 1995; 87: 1456-1462 https://doi.org/10.1093/jnci/87.19.1456
  21. Gaziano JM, Hennekens CH. Dietary fat and risk of prostate cancer. J Natl Cancer Inst 1995; 87: 1427-1428 https://doi.org/10.1093/jnci/87.19.1427
  22. Coffey DS, Walsh PC. Clinical and experimental studies of benign prostatic hyperplasia. Urol Clin North Am 1990; 17: 461-475
  23. Kiyosawa H, Sugawara C, Sugawaro N, Miyake H. Effect of milk and yogurt on serum lipids and development of sudanophilic lessions cholesterol-fed rabbits. Am J Cin Nutr 1984; 40: 479-484 https://doi.org/10.1093/ajcn/40.3.479
  24. Wilson PWF, Castelli WP, Kannel WB. Coronary risk prediction in adults: The Framingham Heart Study. Am J Cardiol 1987; 59: 31-94
  25. Barr SL, McCarron DA, Heaney RP. Effects of increased cinsumption of fluid milk on energy and nutrient intake, body weight, and cardiovascular risk facters in healthy older adults. Am J Diet Assoc 2000; 100: 810-817 https://doi.org/10.1016/S0002-8223(00)00236-4
  26. Platz EA, Rimm EB, Kawachi I, Colditz GA, Stampfer MJ, Willett WC, Giovannucci E. Alcohol consumption, cigarette smoking, and risk of benign prostatic hyperplasia. Am J Epidemiol 1999; 149(2): 106-115 https://doi.org/10.1093/oxfordjournals.aje.a009775
  27. Lee E, Park MS, Shin C, Lee H, Yoo K, Kim Y, et al. A high-risk group for prostatism: a population-based epidemiological study in Korea. Br J Urol 1997; 79: 736-741 https://doi.org/10.1046/j.1464-410X.1997.00149.x
  28. Hwang SH, Kim JI, Sung CJ. Analysis of dietary fiber content of some vegetables, mushrooms, fruits and seaweeds. Korean J Nutr 1996; 29(1): 89-96
  29. Anderson JW, Tietyen-clark J. Dietary fiber: Hyperlipidemia, hypertension, and coronary heart disease. Am J Gastroent 1986; 81: 907-919
  30. Anderson JW, Gustafson NJ, Bryant CA, Tietyen-clark J. Dietary fiber and diabetes: A comprehensive review and practical application. J Am Dietetic Assoc 1987; 87: 1189-1197
  31. Dunzendorfer U, Drahovsky D. C-peptide, testosterone, estrogen, cortisol and zinc in patients with benign hyperplasia of the prostate. Urol Int 1980; 35(5): 369-374 https://doi.org/10.1159/000280350
  32. Willden EG, Robinson MR. Plasma zinc levels in prostatic disease. Br J Urol 1975; 47(3): 295-299 https://doi.org/10.1111/j.1464-410X.1975.tb03968.x
  33. Wilson JD. The pathogenesis of benign prostatic hyperplasia. Am J Med 1980; 68: 745-755 https://doi.org/10.1016/0002-9343(80)90267-3
  34. Morrison AS. Prostatic hypertrophy in Great Boston. J Chronic Dis 1978; 31: 357-362 https://doi.org/10.1016/0021-9681(78)90052-8
  35. Greenwald P, Kimss V, Polan AK, Dick VS. Cancer of the prostate among men with benign prostatic hyperplasia. J Natl Cancer Inst 1974; 53: 335-340 https://doi.org/10.1093/jnci/53.2.335
  36. Kristal AR, Arnold KB, Schenk JM, Neuhouser ML, Weiss N, Goodman P, Antvelink CM, Penson DF, Thompson IM. Race/ ethnicity, obesity, health related behaviors and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial. J Urol 2007; 177(4): 1395-400 https://doi.org/10.1016/j.juro.2006.11.065
  37. Kupeli B, Soygur T, Aydos K, Ozdiler E, Kupeli S. The role of cigarette smoking in prostatic enlargement. Br J Urol 1997; 80 (2): 201-204 https://doi.org/10.1046/j.1464-410X.1997.00299.x
  38. Dai WS, Gutai JP, Kuller LH, Cauley JA. Cigarette smoking and serum sex hormones in men. Am J Epidemiol 1988; 128: 796-805 https://doi.org/10.1093/oxfordjournals.aje.a115033
  39. Barrett-Connor E, Khaw KT. Cigarette smoking and increased endogenous estrogen levels in men. Am J Epidemiol 1987; 126 (2): 187-192 https://doi.org/10.1093/aje/126.2.187
  40. Krieg M, Nass R, Tunn S. Effect of aging on endogenous level of 5 alpha-dihydrotestosterone, testosterone, estradiol, and estrone in epithelium and stroma of normal and hyperplastic human prostate. J Clin Endocrinol Metab 1993; 77: 375-381 https://doi.org/10.1210/jc.77.2.375
  41. Platz EA, Kawachi I, Rimm EB, Colditz GA, Stampfer MJ, Willett WC, Giovannucci E. Physical activity and benign prostatic hyperplasia. Arch Intern Med 1998; 158(21): 2349-2356 https://doi.org/10.1001/archinte.158.21.2349
  42. Meigs JB, Mohr B, Barry MJ, Collins MM, McKinlay JB. Risk factors for clinical benign prostatic hyperplasia in a communitybased population of healthy aging men. J Clin Epidemiol 2001; 54: 935-944 https://doi.org/10.1016/S0895-4356(01)00351-1
  43. Gann PH, Hennekens CH, Longcope C, Verhoek-Oftedahl W, Grodstein F, Stampfer MJ. A prospective study of plasma hormone levels, non hormone factors, and development of benign prostatic hyperplasia. Prostate 1995; 26: 40-49 https://doi.org/10.1002/pros.2990260109